INTRODUCTION {#s1}
============

Rhodosporidium toruloides (also known as Rhodotorula toruloides) is a basidiomycetous yeast that has attracted interest for its great bioengineering potential. The oleaginous yeast can be readily cultivated in high-density cell cultures ([@B1]) and naturally accumulates large quantities of both carotenoids and lipids ([@B2]) which serve as precursors for many valuable compounds. Complementing this is the ability of *R. toruloides* to efficiently consume a wide variety of carbon sources, including those found in lignocellulose hydrolysates ([@B3], [@B4]). Furthermore, *R. toruloides* can grow robustly under difficult environmental conditions, including high osmotic stress ([@B5]) and the presence of ionic liquids used in pretreatment processes ([@B6][@B7][@B8]). It is therefore being assessed as a novel platform for the industrial-scale generation of valuable commodities, including biofuels, pharmaceuticals, and other advanced bioproducts ([@B9][@B10][@B12]).

Despite these advantages, commercial adoption of *R. toruloides* will be hampered until effective genetic engineering tools are developed in this system ([@B13][@B14][@B15]). Notably, no autonomously replicating sequences (ARS) have been identified for use in *R. toruloides*, meaning that all genetic manipulation of this organism to date has been accomplished by direct integration of heterologous DNA elements into the genome. The genetic engineering toolkit for *R. toruloides* has been expanded in recent years with the development of transformation techniques such as Agrobacterium tumefaciens-mediated transformation (ATMT) ([@B16]), electroporation ([@B15], [@B17]), and lithium acetate chemical transformation ([@B14]), which have enabled both efficient random integration based on the nonhomologous end joining (NHEJ) pathway and targeted deletion/integration based on homologous recombination (HR) ([@B18], [@B19]).

Concurrent with these advances is a revolution in the field of genome engineering brought on by the development of precise genome and transcriptome editing through clustered regularly interspaced short palindromic repeat (CRISPR)-based systems ([@B20][@B21][@B22]). Modern genetic engineering approaches in other organisms have largely gravitated toward using CRISPR systems to enact desired DNA changes ([@B23][@B24][@B25]). This approach utilizes a ribonucleoprotein complex (RNP) consisting of a CRISPR-associated nuclease (Cas; the most common being Cas9) and a synthetic single guide RNA (sgRNA). The sgRNA contains an ∼20-nucleotide (nt) spacer sequence complementary to a unique DNA sequence in the targeted organism, as well as a 76-nt handle that complexes with Cas9. By modifying the 20-nt spacer sequence of the sgRNA, researchers can direct the nuclease to a specific location and enact targeted DNA cleavage.

While CRISPR-Cas9 has revolutionized the world of genome editing, it has yet to be demonstrated in *R. toruloides*. The yeast's potential as a robust host for the production of bioproducts would be significantly improved by the development of CRISPR-Cas9 strategies for engineering its genome, especially considering that the genetic engineering toolkit for *R. toruloides* has fallen behind that of more developed yeasts such as Yarrowia lipolytica ([@B26][@B27][@B29]). Cas9 engineering is more amenable to multiplexed gene editing than the current techniques for manipulating *R. toruloides*' genome based on ATMT ([@B30]). Furthermore, CRISPR-Cas9 edits can be employed in a matter of days ([@B31]), while ATMT gene editing can take anywhere from 2 weeks to 1 month ([@B16]). Another advantage of CRISPR-Cas9 gene editing is that it can utilize NHEJ to create site-specific gene deletions, while current techniques relying on HR via *KU70* deletion of the NHEJ repair pathway suffer from the apparent low activity of HR repair relative to NHEJ in *R. toruloides* ([@B15], [@B32]). Targeted gene disruptions would likely be more easily accomplished utilizing CRISPR-Cas9 targeting followed by error-prone NHEJ repair than the current approach.

Here we demonstrate the first application of gene editing using CRISPR-Cas9 in *R. toruloides*. Genomic integration of the coding sequences of Cas9 and an associated sgRNA allows for targeted gene disruption of *URA3* upon (likely NHEJ-based) repair of DNA cleavage. Although initial editing efficiency was low (0.0017% ± 0.0011%), optimizing expression of the sgRNA and fine-tuning of its target sequence led to a 364-fold improvement in editing success of up to 0.62% ± 0.50%. Using the design principles learned in targeting *URA3*, we developed CRISPR-Cas9 constructs to disrupt the carotenoid biosynthesis gene, *CAR2*. Attempts to delete this gene resulted in significantly greater success, with editing efficiencies reaching up to 46% ± 22% of all cells transformed with the CRISPR-Cas9 expression cassette. We further show that multiplexed gene disruption of the *R. toruloides* genome is possible using this approach. Combining an array of four sgRNAs separated by self-processing tRNA elements successfully allowed for targeted deletions of both *CAR2* and *URA3* in one simultaneous transformation. We observed both indels near each cut site and complete deletion of the region between the cut sites. We demonstrate that by using two sgRNAs to disrupt each gene, the intergenic region between these two cut sites can be excised during the DNA repair process. Interestingly, *R. toruloides* demonstrated a propensity to reinsert the excised DNA in its reverse orientation, further supporting the observation that the organism is particularly effective at accomplishing NHEJ-based DNA repair. Taken together, these results outline a strategy for achieving efficient CRISPR-based genome editing in *R. toruloides* and will streamline metabolic engineering efforts in this industrially relevant organism.

RESULTS {#s2}
=======

Integration of Cas9 and sgRNA into *R. toruloides*' genome allows for targeted gene disruption. {#s2.1}
-----------------------------------------------------------------------------------------------

We first designed a Cas9 expression construct for use in *R. toruloides*. This included codon optimization, addition of a nuclear localization sequence (NLS) to Cas9, and selection of the native GAPDH promoter for constitutive expression. An sgRNA expression cassette was placed upstream of the Cas9 sequence cassette consisting of a promoter, a hepatitis delta virus (HDV) ribozyme cleavage sequence, a 20-nt unique gene targeting sequence, a 76-nt common sgRNA handle for the association of Cas9 with the RNA, and a terminator sequence. The SNR52 RNA polymerase III promoter and terminator sequences from Saccharomyces cerevisiae were employed to drive expression of this sgRNA, as they have been used successfully in other fungi ([@B33], [@B34]). Placing a ribozyme element between the SNR52 promoter and the sgRNA element resulted in a 6-fold increase of sgRNA abundance in S. cerevisiae in our previous work ([@B35]). The ribozyme was therefore included in the hopes of increasing the abundance of any sgRNA produced from the SNR52 promoter and increasing editing efficiency in *R. toruloides*.

To validate this CRISPR-Cas9 system, the *URA3* gene encoding orotidine 5′-phosphate decarboxylase was targeted for deletion. Expression of the decarboxylase is known to allow yeast to convert 5-fluoroorotic acid (5-FOA) into 5-fluorouracil, a compound that is highly toxic to most yeast ([@B36]). Therefore, successful editing (i.e., loss of function of *URA3* caused by error-prone NHEJ repair of the Cas9-mediated dsDNA break) can be selected for by growth in the presence of 5-FOA.

The first attempt to generate edits at the *URA3* locus was done in a single-step by transforming a PCR fragment containing both the Cas9 and a *URA3*-specific sgRNA expression cassette, followed by selection on 5-FOA plates ([Fig. 1A](#fig1){ref-type="fig"}). The number of 5-FOA-resistant (5-FOA^r^) colonies obtained in the presence of the Cas9/sgRNA cassette was indistinguishable from a control transformation in the absence of the PCR fragment, suggesting that editing, if it occurred, was no more frequent than the rate of spontaneous 5-FOA^r^ ([Fig. 1B](#fig1){ref-type="fig"}). Sequencing DNA from three 5-FOA^r^ colonies near the cut site of Cas9 revealed that a consistent frameshift occurred outside the target sequence ([Fig. 1C](#fig1){ref-type="fig"}). This suggests that 5-FOA^r^ arose not from Cas9-mediated gene disruption but through spontaneous mutation of *URA3* leading to loss of function. We thought that this failure in Cas9-based gene editing may have been due to poor expression of the sgRNA from the nonnative SNR52 promoter sequence, or due to targeting an area of the genome not amenable to Cas9 binding. However, even upon replacing the SNR52 promoter with four other variants, and utilizing an alternative sgRNA, no improvement in 5-FOA^r^ colony formation was observed (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Of the 10 promoter-target variants tested, none exhibited statistically significant increases in 5-FOA^r^ colony formation over the negative control. Indeed, sequencing 12 5-FOA^r^ transformants revealed that each resulted in the same spontaneous mutation outside the Cas9 cut site, supporting the notion that this approach fails to induce targeted Cas9 cleavage ([Fig. S1](#figS1){ref-type="supplementary-material"}).

![Targeted gene disruption using CRISPR-Cas9. (A) Schematic of original CRISPR-Cas9 design for causing indels in *R. toruloides*. A PCR fragment containing the coding sequences for expressing sgRNA and Cas9 is transformed into competent cells, which take up the DNA into their nucleus and express the machinery from the PCR fragment. (B) Total CFU of *R. toruloides* under 5-FOA selection with and without application of this CRISPR-Cas9 editing scheme. (C) Partial sequencing of *URA3* of each potentially edited colony near the cut site of Cas9. (D) Revised protocol in which the coding sequence for a selectable marker is included in the PCR fragment and an additional selection step for integration of the fragment into the genome is included. (E) Total CFU of *R. toruloides* under 5-FOA selection with this revised CRISPR-Cas9 editing scheme. Significance was calculated using a two-tailed type II Student *t* test. (F) Partial sequencing of *URA3* of three edited colonies near the cut site of Cas9. All error bars represent the standard deviation of biological triplicates.](mSphere.00099-19-f0001){#fig1}
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\(A\) CFU of *R. toruloides* upon transformation of various CRISPR expression constructs in which the sgRNA is expressed under various promoters, using the approach outlined in [Fig. 1A](#fig1){ref-type="fig"}. The original promoter is highlighted in blue, while transformation with no transforming DNA in wild-type *R. toruloides* is highlighted in yellow. The source of the promoter sequence as either S. cerevisiae (Sc) or *R. toruloides* (Rt) is listed in parentheses. Error bars represent the standard deviation of biological triplicates. A two-tailed type II Student *t* test was performed comparing the CFU of the wild type to the other 10 samples, but no significant differences were observed. (B) Sequencing results of various replicates selected from transformed plates of sgRNA target 1. The Cas9 cut site is indicated, while indels are highlighted in blue. Download FIG S1, TIF file, 2.7 MB.
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It was hypothesized that this failure of Cas9-mediated gene editing was due to insufficient expression of the CRISPR machinery during the transformation process. To alleviate this problem, a new approach was employed in which the CRISPR cassette was first targeted for stable integration using a selectable drug marker cassette that encodes nourseothricin resistance (NAT^r^) before screening for successful *URA3* editing ([Fig. 1D](#fig1){ref-type="fig"}).

Approximately 300 NAT^r^ colonies were obtained after transformation, and three colonies were selected for subsequent screening of Cas9-mediated DNA editing. Growing each colony in YPD followed by plating on YPD supplemented with 5-FOA resulted in 93 ± 40 colonies ([Fig. 1E](#fig1){ref-type="fig"}). A control transformation of NAT^r^ without the CRISPR cassette resulted in significantly fewer spontaneously 5-FOA^r^ colonies (1.6 ± 0.5) This was significantly above the background level of spontaneous 5-FOA^r^ observed utilizing the same process in the control transformation with no PCR DNA (*P* = 0.02). Furthermore, sequencing revealed indels near the cut site that resulted in frameshifts, suggesting that error-prone NHEJ repair occurred in a specific location dictated by the sgRNA sequence ([Fig. 1F](#fig1){ref-type="fig"}). Utilizing the other four promoter variants also resulted in successful gene disruption at the Cas9 cut site ([Fig. S2](#figS2){ref-type="supplementary-material"}).
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\(A\) CFU of *R. toruloides* upon transformation of various CRISPR expression constructs in which the sgRNA is expressed under various promoters, using the approach outlined in [Fig. 1D](#fig1){ref-type="fig"} using sgRNA target 2. The original promoter is highlighted in blue, while transformation with a NAT^r^ cassette excluding the Cas9 and sgRNA sequences into wild-type *R. toruloides* is highlighted in yellow. The source of the promoter sequence as either S. cerevisiae (SC) or *R. toruloides* (RT) is listed in parentheses. (B) Editing efficiencies of each construct, determined as the ratio of 5-FOA^r^ CFU to NAT^r^ CFU. The low level of construct RT tRNA^Pro^ 5-FOA^r^ CFU was due to a low number of overall cells used in the transformation; when this was taken into account, editing efficiencies of this construct were similar to the original construct. Additionally, the "editing efficiency" due to spontaneous mutation of 5-FOA^r^ was calculated from the NAT^r^ control transformation. Error bars represent the standard deviation of biological triplicates. *P* values were calculated using a two-tailed type II Student *t* test with comparison to the NAT^r^ control. (C) Sequencing results of various replicates selected from transformed plates. The Cas9 cut site is indicated, while indels are highlighted in blue. Download FIG S2, TIF file, 2.3 MB.
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These results indicate that stable integration of a Cas9-sgRNA expression cassette into the genome allows for successful gene editing in *R. toruloides*. Additionally, growth curves of wild-type cells and cells harboring the Cas9-sgRNA cassette show no difference in growth rates, indicating that the cassette does not elicit detrimental fitness effects ([Fig. S3](#figS3){ref-type="supplementary-material"}). However, while the CRISPR-Cas9 system was able to disrupt genes, the efficiency of this process was low. The efficiency of gene editing was determined by comparing the total amount of CFU in the presence of 5-FOA to CFU in the absence of 5-FOA. Total CFU were roughly 10^5^-fold higher in the absence of 5-FOA, indicating that Cas9 editing efficiency was on the order of ∼0.001%.
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Growth of wild-type *R. toruloides* in comparison to *R. toruloides* harboring a genome-integrated Cas9 expression cassette. Growth was performed in YPD supplemented with no antibiotics. Download FIG S3, TIF file, 1.5 MB.

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Due to this overall low editing efficiency, focus shifted to the optimization of editing efficiency. We initially sought to improve editing efficiency by adding an additional NLS, as using two ([@B37]) or three ([@B38]) NLSs in tandem has previously been shown to increase editing efficiency due to improved nuclear localization ([@B39]). However, our initial tests attempting to improve Cas9 editing by adding an additional NLS resulted in a 6.6-fold decrease in editing efficiency ([Fig. S4](#figS4){ref-type="supplementary-material"}), so improvement in the design of the sgRNA sequence was pursued in the following experiments.
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Effect of additional NLS on Cas9 editing efficiency. We first used the SV40 NLS, as it has been shown to work well in a variety of fungal systems. However, we thought editing efficiency might be improved by adding an additional NLS to the Cas9 sequence. To test this, we included a second SV40 NLS downstream of the first. However, this change significantly (*P* = 0.0003) reduced editing efficiency roughly ∼7-fold, from 0.0032% ± 0.0004% to 0.00049% ± 0.00006%. We therefore do not recommend this approach in *R. toruloides*. Download FIG S4, TIF file, 1.5 MB.
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sgRNA target optimization. {#s2.2}
--------------------------

The first point of optimization in the sgRNA design was to reconsider the 20-nt DNA targeting sequence used in the sgRNA. Complex secondary structure near the DNA target sequence can lead to significant hindrance to Cas9 activity ([@B40]). Therefore, the program sgRNA Scorer 2.0 was used to optimize target sequences of Cas9 ([@B41]). This program is based on sgRNA design principles uncovered in human cell lines, and while it has been utilized to design successful sgRNAs for Cas9 editing in yeast ([@B42]), its applicability outside human cell lines is not well known. Therefore, seven new target sequences for *URA3* were selected representing a range of different predicted scores, and a series of new editing constructs were generated (plasmids 213 to 233 \[[Table S1](#tabS1){ref-type="supplementary-material"}\]) to test their relative editing efficiency. Altering the sgRNA targeting sequence had a noticeable impact on editing efficiency. In the optimal case, editing efficiency was improved ∼14-fold over the original sgRNA target sequence, while the sgRNA predicted to perform worst reduced editing efficiency ∼9-fold ([Fig. 2A](#fig2){ref-type="fig"}). This indicates that sgRNA target optimization is important for achieving acceptable levels of editing efficiency in *R. toruloides* and that established design tools can facilitate construction of new sgRNA targets.

![Optimization of sgRNA expression and target sequence. (A) Editing efficiency of various sgRNA target sequences. Bars indicate measured CRISPR-Cas9 gene editing efficiency, as a percentage of the total cells in the transformation mixture exhibiting the expected edited phenotype. Significant differences from the original target sequence (highlighted in blue, *P* \< 0.05) are indicated by asterisks and calculated using a two-tailed type II Student *t* test. The predicted aptitude for a target sequence to achieve successful DNA editing based on the sgRNA Scorer 2.0 algorithm ([@B41]) is depicted in parentheses after each target sequence. (B) Measured editing efficiency of sgRNA with and without an HDV ribozyme cleavage site included between the promoter and the 20-nt target sequence. (C) Measured editing efficiency of various promoters used to drive sgRNA expression. All asterisks indicate statistical difference from the original expression design (highlighted in blue, *P* \< 0.05) calculated using a two-tailed type II Student *t* test. Error bars represent the standard deviation of biological triplicates.](mSphere.00099-19-f0002){#fig2}
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Plasmids used in this study. All plasmids are available per request from the Inventory of Composable Elements (ICE) maintained by the Joint BioEnergy Institute (accessible via <https://registry.jbei.org>). Download Table S1, PDF file, 0.08 MB.
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Another point of optimization was the ribozyme included between the sgRNA promoter and the 20-nt guide sequence. The ribozyme was originally included for its potential to protect the 5′ end of the sgRNA from 5′ exonucleases and was found to aid in improving editing efficiencies in S. cerevisiae ([@B35], [@B43]). The ribozyme was removed to see if this was the case. This alteration caused the editing efficiency to increase 26-fold ([Fig. 2B](#fig2){ref-type="fig"}), significantly improving Cas9-directed gene editing (*P* = 0.004). As such, we recommend the exclusion of the 5′ HDV ribozyme in designing sgRNAs for expression in *R. toruloides*.

Alternatives to the promoter sequence used in driving sgRNA expression were explored next. A variety of RNA Pol III promoters were examined, each excluding the detrimental ribozyme element. The original SNR52 promoter used here, which was originally derived from S. cerevisiae, was replaced with an analogous SNR52 promoter element from another oleaginous yeast, Y. lipolytica, as this sequence has been proven to produce functional sgRNAs in other systems ([@B44]). However, this change made no significant impact on editing efficiency ([Fig. 2C](#fig2){ref-type="fig"}). Since it is unknown if SNR52 exists in *R. toruloides*, a native SNR52 sequence for driving sgRNA expression could not be used.

To utilize a native *R. toruloides* sequence, we turned to an alternative promoter system to drive sgRNA expression. Work in other fungi has found that tRNAs can serve as promoters for sgRNAs *in vivo* either individually ([@B35], [@B45]) or downstream of an SNR52 promoter ([@B44]). Furthermore, tRNAs contain internal elements that promote RNase P- and Z-mediated cleavage at specific sites, allowing for formation of precise final sgRNA sequences. Including the *R. toruloides* tRNA^Tyr^ sequence downstream of the S. cerevisiae SNR52 promoter increased editing efficiency slightly (1.8-fold) but significantly (*P* = 0.02) ([Fig. 2C](#fig2){ref-type="fig"}). Furthermore, directly replacing the SNR52 promoter with tRNAs led to successful editing. This was particularly true of tRNA^Phe^ and tRNA^Tyr^, whose use as sgRNA promoters led to editing efficiencies 14-fold and 13-fold greater, respectively (or 0.62% ± 0.50% and 0.59% ± 0.34% editing efficiency, respectively). These tRNAs were also tested with the HDV ribozyme included between the promoter and the sgRNA. However, inclusion of the HDV ribozyme reduced editing efficiencies of the tRNA^Phe^ and tRNA^Tyr^ constructs 145-fold and 311-fold, respectively ([Fig. S2](#figS2){ref-type="supplementary-material"}), lending further evidence that the ribozyme design approach is ill advised in *R. toruloides*.

Taken together, these results indicate that native *R. toruloides* tRNA promoters are more effective than heterologous SNR52 promoters for Cas9-based gene editing. This could be due to increased sgRNA expression, although this remains to be tested.

Multiplexed gene disruption with CRISPR-Cas9. {#s2.3}
---------------------------------------------

In order to develop a multiplex gene editing system for *R. toruloides*, a second target gene was selected, *CAR2*, a gene that encodes a phytoene synthase/lycopene cyclase protein that is essential for carotenoid biosynthesis ([@B46]). Loss of *CAR2* function is easily observed as a change in colony color from red to white.

A set of single guides targeting *CAR2* were first designed to disrupt the *CAR2* locus, and their editing efficiencies were tested. Four different Cas9-sgRNA-NAT^r^ constructs were built using the design principles discovered for *URA3* editing and transformed into *R. toruloides*. After stable integration using the NAT^r^ selection method and replating, a significant number of white colonies for all four sgRNA variants were observed. Editing efficiencies (determined as the ratio of white to red colonies) ranged from 3.4% ± 2.7% to 46.2% ± 22.2% ([Fig. 3A](#fig3){ref-type="fig"}). Notably, these levels of editing efficiency are substantially higher for *CAR2* than for any of the *URA3* targeting constructs, indicating that this genome region is more amenable to Cas9-based genome editing. Furthermore, successful disruption of *CAR2* indicates that multiplexed gene editing might be possible by selecting for 5-FOA^r^ colonies that exhibit a white phenotype.

![Multiplexed gene disruption using CRISPR-Cas9 in *R. toruloides*. (A) Editing efficiency of four sgRNAs targeting *CAR2.* Error bars represent standard deviations of biological triplicates. (B) The design used to express multiple sgRNAs in a single array. The specific cut sites for *URA3* and *CAR2* are shown below. Guides "a" and "b" correspond to sgRNAs "4" and "3" for *URA3*, respectively, while guides "c" and "d" correspond to sgRNAs "1" and "3" for *CAR2*, respectively, based on the sequences presented in [Table S3](#tabS3){ref-type="supplementary-material"}. (C) 5-FOA plate with colonies demonstrating successful simultaneous disruption of the two genes. To the right is shown the editing efficiency of disrupting each gene individually, as well as tandem gene-disruption editing efficiency. (D and E) Gel image showing PCR amplification of genomic DNA of eight unique colonies near the targeted cut site of *URA3* (D) or *CAR2* (E). (F) Sequencing results near the target cut site of the eight *URA3* PCR products from panel D. Cas9 cut sites are indicated, as well as the DNA size of the excised DNA fragment between each cut site. Mutations are highlighted in blue. (G) Sequencing results near the target cut site of the eight *CAR2* PCR products from panel E. Mutations caused by Cas9 targeting are highlighted in blue. All error bars represent standard deviation of biological triplicates.](mSphere.00099-19-f0003){#fig3}

To explore multiplexed deletion of two genes in *R. toruloides*, a Cas9 construct targeting both *URA3* and *CAR2* was created. For this, multiple sgRNAs were placed together sequentially into an array, with each guide RNA separated by a tRNA sequence ([Fig. 3B](#fig3){ref-type="fig"}). This approach has been applied in other organisms to take advantage of inherent tRNA posttranscriptional processing to express multiple unique sgRNA sequences ([@B45], [@B47], [@B48]). Combining multiple sgRNAs in an array is particularly useful for *R. toruloides*, as this minimizes the amount of genetic material that needs to be delivered while maximizing the number of potential gene targets. Additionally, utilizing multiple sgRNAs to target one gene at different locations allows for the possibility of removing a large DNA region in between the target sites and also increases the possibility that the target gene is successfully disrupted ([@B20], [@B49], [@B50]). Therefore, our constructs were designed to express four sgRNAs (two for each gene) such that cleavage would occur at two sites separated by ∼500 bp in both genes.

The multiplexed CRISPR editing construct fragment was transformed into *R. toruloides*, and multiple NAT^r^ colonies were selected to screen for genetic disruptions. To determine loss of *CAR2* function, we grew colonies overnight in liquid cultures, which were subsequently plated on NAT plates. Colonies were then screened for their red or white phenotypes. This provided an estimate of the editing efficiency of *CAR2*, which was determined to be 3.2% ± 0.5%, independently of the editing efficiency of *URA3*. To determine loss of *URA3* function, an equal volume of each culture was plated on both NAT and 5-FOA plates and the CFU counts on each plate were compared. This provided an estimate of the editing efficiency of *URA3* of 1.1% ± 0.8%. Colonies growing on 5-FOA were also screened for their red or white phenotypes to determine the dual-gene disruption efficiency. Of the 5-FOA^r^ colonies, 30.0% ± 8.0% exhibited a white phenotype, indicating simultaneous *CAR2* and *URA3* disruption ([Fig. 3C](#fig3){ref-type="fig"}).

We next sought to confirm that these edits were indeed the result of successful Cas9-mediated editing. For this, eight white colonies were selected from the 5-FOA plates and the regions of *URA3* and *CAR2* which surrounded the Cas9 target sites were PCR amplified. Gel electrophoresis of these PCR products revealed that several of the samples shrank significantly from the predicted size of the wild-type PCR products (717 nt and 1,637 nt for *URA3* and *CAR2*, respectively) ([Fig. 3D](#fig3){ref-type="fig"} and [E](#fig3){ref-type="fig"}).

Sequence verification of these fragments was employed around the target cut sites to see what type of gene editing events occurred ([Fig. 3F](#fig3){ref-type="fig"} and [G](#fig3){ref-type="fig"}). Sequencing revealed that most of the cut sites contained indels resulting in frameshift mutations. Cas9-based gene editing was observed at both target sites for each gene in seven out of eight transformants. Transformants 3 and 8 demonstrated complete excision of the intergenic region between the two *URA3* cut sites, while transformant 4 surprisingly demonstrated reintegration of the intergenic region in its reverse direction. Similarly, editing of *CAR2* occurred in every transformant at cut site "c," and at cut site "d" in all samples excluding transformants 3, 6, and 7. Transformants 4, 5, and 8 demonstrated complete removal of the intergenic region between the two *CAR2* cut sites. Again, transformants 1 and 2 demonstrated the surprising evidence of reintegration of the reverse direction of the intergenic region. Taken together, these results demonstrate that multiplexed gene disruption mediated by CRISPR-Cas9 is possible in a single transformation of *R. toruloides*.

DISCUSSION {#s3}
==========

The development of CRISPR-Cas9 technology has revolutionized genome engineering. Scientists are now able to rapidly edit the DNA of organisms where genetic manipulation was previously inefficient or intractable ([@B51]). The fundamental science underlying CRISPR engineering of genomes remains constant regardless of the organism being investigated; scientists use these nucleases to induce DNA cuts at highly specific locations and rely upon the organism's DNA repair machinery to mend these breaks with donor DNA (via HR) or in an error-prone fashion (via NHEJ). However, the process of delivering and expressing fully functional CRISPR components, and the biology of each organism's DNA repair pathways, requires organism-specific optimization to accommodate each species' unique characteristics. The past few years have seen the publication of a wide array of studies demonstrating CRISPR-Cas9 genome engineering in fungal species for which few robust DNA editing tools existed, including Aspergillus niger ([@B52]), Cryptococcus neoformans ([@B53]), Mucor circinelloides ([@B54]), and Myceliophthora thermophila ([@B50]). The dawning of a "fungal CRISPR revolution" has occurred, empowering researchers to explore new bioproduction possibilities in obscure yet promising fungi.

Here we add *R. toruloides* to the list of fungi now editable using CRISPR-Cas9. While this yeast has been touted for its great bioproduction potential, the sparse genetic manipulation toolkit relative to other organisms such as Y. lipolytica ([@B27]) previously hindered engineering efforts ([@B55][@B56][@B58]). The past 4 years have seen various researchers remedy this problem with the development of tools for transforming *R. toruloides* and efficiently expressing exogenous DNA ([@B15], [@B59]). While the toolkit has expanded to include useful promoters ([@B56]), drug markers ([@B11]), and targeted gene editing methods ([@B18]), CRISPR-Cas9 methods for advanced genome engineering have been lacking. This study outlines the strategies by which researchers can employ multiplexed CRISPR-Cas9 genome editing to manipulate *R. toruloides*. These are the first steps to ultimately achieving more sophisticated genome- or transcriptome-scale engineering of *R. toruloides*, an important step toward fulfilling the organism's potential.

Accomplishing this required overcoming significant barriers. Most notably, the lack of a plasmid capable of replicating in *R. toruloides* to express CRISPR constructs, the most common method for employing CRISPR editing in other fungi ([@B24]), requires alternative approaches to express the editing system. One approach to accomplish this would be to directly transform fully assembled Cas9-sgRNA RNP complexes ([@B53]). Such an approach has proven successful in the distant basidiomycete relative Cryptococcus neoformans ([@B53]), suggesting that it may one day prove successful in *R. toruloides.* An alternate approach involving the delivery of DNA coding for CRISPR machinery was explored in this study. We demonstrated that stable genome integration of a Cas9-sgRNA expression cassette using a dominant selectable drug marker is sufficient to achieve gene disruption.

The next major barrier we overcame was the successful expression of sgRNAs intracellularly. This requires a robust RNA Pol III promoter in order to achieve high expression of the guides inside the nucleus. *R. toruloides*, like many other nonmodel fungi, has poorly explored Pol III promoter systems ([@B60]). We therefore explored a variety of such promoters, as well as RNA processing elements, including ribozymes and self-splicing tRNAs. We found the optimal sgRNA expression system to be tRNA-driven guides, preferably using designs guided from sgRNA prediction programs, such as sgRNA Scorer ([@B41]). There is conflicting evidence in the literature as to whether inclusion of a ribozyme element improves sgRNA expression, with some studies finding that it increases editing efficiency ([@B35], [@B43]) while others find the opposite effect ([@B61]). Here, our results indicate that ribozyme inclusion is detrimental to Cas9 editing efficiency in *R. toruloides*. Additionally, we demonstrated that multiple functional sgRNAs can be expressed from a single construct using the tRNA processing system described in previous works ([@B47], [@B48]). The low level of editing efficiency in this multiplexed sgRNA design, relative to the editing efficiency levels of the sgRNAs expressed independently (especially *CAR2* sgRNAs), indicates that further optimization of this design could enhance multiplexed gene editing. This could include ensuring high levels of endogenous expression and efficient processing of the transcript into individual sgRNAs. While the potential for optimization remains, our work toward optimized sgRNA expression provides design guidelines for future CRISPR engineering efforts in *R. toruloides*.

A significant locus-dependent editing efficiency was observed in our study. Despite much of our work focusing on optimization of *URA3* deletion with Cas9, we achieved a relatively low maximum editing efficiency at this locus of 0.62% ± 0.50%. However, deletion of *CAR2* was markedly more successful in even the worst-case scenario (3.4% ± 2.7%), while the best-case scenario resulted in roughly a one-to-one ratio of white to red colonies. The locus dependency of Cas9 editing efficiency has been noted in other non-yeast eukaryotic systems ([@B23], [@B62], [@B63]). Combined with the qualitatively large differences observed between editing efficiencies of Cas9 at various *URA3* target locations, optimization of the Cas9 target sequence appears to be particularly important for editing in *R. toruloides*. Transient Cas9 binding events are known to occur much more frequently than actual cleavage occurs, and changes in the protein's conformation upon binding to the correct target sequence dictate whether DNA cutting actually occurs ([@B64]). Furthermore, the high GC content of the *R. toruloides* genome should be taken into consideration ([@B65]). A correlation between high GC content and lower Cas9 target specificity has been noted ([@B66]), raising the possibility that Cas9 cleavage in *R. toruloides* is (i) more promiscuous or (ii) less effective. A thorough exploration of genome editing efficiencies of Cas9 at various locations in *R. toruloides*' genome would assist in future genome editing endeavors in the organism.

The ability to achieve multiple DNA edits in one round of transformation is an important step forward in *R. toruloides* genome engineering. Thus far, multiple gene edits have been accomplished utilizing multiple rounds of ATMT in which genes are disrupted one at a time; here we have demonstrated that four simultaneous DNA edits can be achieved at once. The sgRNA array could theoretically be expanded to include even more targets. It should be noted that a reduction in editing efficiency may occur with sgRNAs located further downstream in the array. This is supported by the fact that the editing efficiency of *URA3* deletion was relatively similar in the individual and multiplexed targeting constructs (where the targets were located upstream), but the editing efficiency of *CAR2* deletion was substantially lower in the multiplexed targeting construct (where the targets were located downstream) than in the individual targeting case. The multiplexed targeting construct also reveals an interesting phenomenon in which excised DNA between two nearby CRISPR-Cas9 cut sites was inverted and reinserted into the genome. This is potentially due to the relatively high level of NHEJ in *R. toruloides* ([@B15]) and indicates that genome integration of exogenous DNA at Cas9 cut sites may be possible if donor DNA can be supplied concurrently with Cas9 cleavage. Inversions of DNA between two nearby Cas9 cut sites have been reported in *Arabidopsis*, suggesting that this phenomenon is not unique to *R. toruloides* ([@B67]).

Taken together, our work lays the foundation for Cas9-mediated advanced genome editing in *R. toruloides*. Future efforts could improve upon this framework by employing directed integration of the Cas9 cassette into a specific genetic locus in a Δ*KU70* background or on an ARS-based plasmid to circumvent problems arising from random genome integration in the current strategy. Ultimately, these results should enable rapid engineering of complex *R. toruloides* phenotypes, such as multigene pathways to produce biofuels and bioproducts.

MATERIALS AND METHODS {#s4}
=====================

Strains and culture conditions. {#s4.1}
-------------------------------

The strain *R. toruloides* IFO0880 (obtained from Biological Resource Center, NITE \[NRBC\]) was used as the wild-type strain for all experiments. Liquid cultures of yeast were grown in YPD (BD Difco) at 30°C and constant 200-rpm shaking unless otherwise noted. Solid YPD agar plates were used to grow yeast colonies at 30°C and supplemented with the antibiotics nourseothricin (Werner Bioagents; 100 µg/ml) or 5-fluoroorotic acid (Abcam; 1 mg/ml) as appropriate.

For all cloning, Escherichia coli strain XL1-Blue or DH5α was used to propagate plasmids. E. coli was grown in lysogeny broth (LB; BD Difco) at 37°C with 200-rpm shaking. Where appropriate, E. coli medium was supplemented with 100 µg/ml ampicillin (or 100 µg/ml carbenicillin in place of ampicillin) or 50 µg/ml kanamycin to maintain plasmids.

Plasmid construction. {#s4.2}
---------------------

The coding sequence of Streptococcus pyogenes spCas9 and the SV40 NLS (PKKKRKV) were codon optimized for expression in *R. toruloides* (GenScript), with a (Gly)~3~ linker included to connect the C terminus of spCas9 to the NLS. The fusion protein was placed under expression of the 800-bp GAPDH promoter sequence and NOS terminator sequence, which is known to promote strong gene expression in *R. toruloides* ([@B2], [@B57]). The desired optimized sequences were synthesized by GenScript and sequence verified. All plasmids were commercially synthesized excluding plasmids p213 and p227 to p233, which were constructed in our lab as follows. Plasmid p213 was first constructed by creating two PCR products from p90 using primers 100 to 103 and subsequently using In-Fusion HD cloning (Clontech) to stitch the PCR products together. Plasmids p227 to p233 were created from p213 using primers 104 to 117 in PCRs to create new sgRNA target sequences in individual PCR products, which were subsequently circularized using In-Fusion HD cloning. Strains, plasmids, and primers used in this study are listed in [Tables S1 to S3](#tabS1){ref-type="supplementary-material"} in the supplemental material and are available from the JBEI Registry (<https://registry.jbei.org/>).

Transforming DNA preparation. {#s4.3}
-----------------------------

DNA for transformation into *R. toruloides* was prepared from the aforementioned E. coli plasmids. To integrate their corresponding Cas9 constructs into the genome, plasmids p90 to p99 and p184 to p190 were digested with HindIII, while plasmids pGI103 to pGI132 were digested with NdeI. Digestion products were subsequently confirmed using gel electrophoresis and purified using a PCR purification kit (DNA Clean & Concentrator; Zymo Research). These purified products were used directly for transformation. An alternative method was used to integrate the corresponding Cas9 constructs on plasmids p213 to p233 into the genome. These plasmids were instead PCR amplified using primers 122 and 123 ([Table S2](#tabS2){ref-type="supplementary-material"}), and the PCR products were subsequently confirmed using gel electrophoresis and purified using a PCR purification kit. These purified PCR products were used directly for transformation. Regardless of DNA preparation method, approximately 500 ng of transforming DNA was used for transformation.
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Transformation. {#s4.4}
---------------

Transformation was performed using a modified lithium acetate (LiAc) protocol ([@B14]). An individual yeast colony was inoculated into 10 ml YPD medium and grown overnight at 30°C with 200-rpm shaking. The following morning, the OD~600~ of this seed culture was measured and used to inoculate 10 ml of fresh YPD to an OD~600~ of 0.2. This culture was grown for another 4 h at 30°C with 200-rpm shaking to an OD~600~ of approximately 1.0. Cells were pelleted via centrifugation at 4,000 × *g* for 5 min, washed twice with 10 ml H~2~O, washed once with 10 ml 150 mM LiAc (Millipore Sigma) at pH 7.6, and resuspended in 1 ml 150 mM LiAc. The pellet was then transferred to 1.5-ml microcentrifuge tubes and centrifuged at 8,000 × *g* for 1 min, and the supernatant was removed using a pipette. The wet biomass was then resuspended in 240 µl 50% (wt/vol) PEG 4000 (Alfa Aesar), 54 µl 1.0 M LiAc,10 µl of preboiled salmon sperm DNA (Invitrogen), and 56 µl of transforming DNA (∼500 ng of purified PCR product). The viscous slurry was resuspended via pipetting and incubated at 30°C for 30 min, after which 34 µl of 1 M dithiothreitol (Millipore Sigma) dissolved in DMSO was added. The transformation was heat shocked at 37°C for 60 min and subsequently pelleted and washed with 1 ml YPD. The culture was then resuspended in 2 ml YPD and incubated overnight at 30°C with 200-rpm shaking. Cells were pelleted, resuspended in 200 µl YPD, and plated on the appropriate selective medium. Utilizing this method to randomly integrate dsDNA via the NHEJ pathway into the *R. toruloides* genome typically provides ∼500 colonies, or a transformation efficiency of ∼1,000 transformants/µg.

Determination of gene edits. {#s4.5}
----------------------------

*R. toruloides* samples transformed with transforming DNA made from plasmids p90 to p99 were plated directly on YPD plates supplemented with 5-FOA and grown for 3 to 4 days. CFU were subsequently determined for each transformation. Three transformations were performed for every construct and plated on independent plates to acquire three biological replicates. Three control samples in which no DNA was included in the transformation were also performed to determine the rate of spontaneous 5-FOA^r^.

*R. toruloides* samples transformed with all other transforming DNA (derived from plasmids p184 to p233 and pGI104 to pGI132) harboring a *NAT* selective marker were plated directly on YPD plates supplemented with nourseothricin and grown for 2 to 3 days. Three colonies were selected from each transformation and grown overnight. For experiments designed to edit the *URA3* locus, serial dilutions of each culture were plated on both YPD and YPD supplemented with 5-FOA and grown for 3 to 4 days. For *CAR2* gene editing experiments, serial dilutions of each culture were plated on YPD. Total CFU were determined from serial dilutions providing between 10 and 1,000 countable colonies. Conversion of the red phenotype to white phenotype was used as a proxy for successful editing of the *CAR2* gene to induce a loss-of-function mutation.

For sequencing, individual colonies were selected from 5-FOA plates and grown overnight in YPD. For [Fig. 1](#fig1){ref-type="fig"} and [Fig. S1](#figS1){ref-type="supplementary-material"} and [S2](#figS2){ref-type="supplementary-material"}, genomic DNA was prepared using a custom protocol of DNA extraction. For this, 200 µl of yeast culture of approximately 0.40 OD~600~ was centrifuged at maximum speed and the supernatant was removed. Pellets were resuspended in 100 µl of 200 mM LiOAc supplemented with 1% SDS and incubated for 15 min at 95°C. The samples were supplemented with 300 µl of 96 to 100% ethanol (EtOH), vortexed thoroughly, and centrifuged at maximum speed for 3 min. The supernatant was aspirated off, and the pellet was washed once with 70% EtOH. The pellet was resuspended in 100 µl H~2~O and pelleted at maximum speed for 15 s. The resulting supernatant containing genomic DNA was recovered for downstream applications. All other genomic DNA was recovered from 100 mg of wet biomass (Quick-DNA Fungal/Bacterial kit; Zymo Research). Genomic DNA quality was examined by running on an agarose gel, and high-quality DNA was used as a template for PCR. The genomic region around the *URA3* or *CAR2* target sites (see [Table S2](#tabS2){ref-type="supplementary-material"} for primers) was amplified via PCR and run on an agarose gel. PCR products were purified and submitted for Sanger sequencing (Quintara Biosciences).
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